SNOA News and Press, Sonoma Pharmaceuticals Inc. From 12/11/20

Gainers: Sonoma Pharmaceuticals (SNOA) +87%.aTyr Pharma (LIFE) +65%.NantHealth (NH) +63%.vTv Therapeutics (VTVT) +55%.Equus Total Return (EQS) +45%Hancock Jaffe Laboratories (HJLI) +34%.MDJM (MDJH) +25%.Foresight Autonomous (FRSX) +23%.Solid Biosciences (SLDB) +22%.22...

Gainers: Sonoma Pharmaceuticals (SNOA) +114%. NantHealth (NH) +110%. vTv Therapeutics (VTVT) +59%. aTyr Pharma (LIFE) +33%. NantKwest (NK) +22%.Losers: SELLAS Life Sciences (SLS) -33%. Immutep (IMMP) -29%. Salarius Pharmaceuticals (SLRX) -29%. Nabriva Therapeutics (NBRV) -29%. ALX O...

Sonoma Pharmaceuticals (SNOA) +35.3% post-market after announcing a partnership with Crown Laboratories for a license and supply agreement for exclusive rights to sell and market products for the over-the-counter dermatological market in the U.S.Under the deal terms, Crown will sell Sonoma's ...

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing high performance stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, oral care, nasal care and dermatological conditions, and Crown...

Sonoma Pharmaceuticals (SNOA): FQ2 GAAP EPS of $0.07.Revenue of $5.77M (+22.0% Y/Y)Shares +5.58%.Press Release For further details see: Sonoma Pharmaceuticals reports FQ2 results

Revenues of $5.8 and $11.5 million increased by 22% for the quarter and 25% for the six months ended September 30, 2020 due to strong international growth Operating Expenses continue to trend down by 33% for second quarter 2021 versus second quarter 2020 Net income p...

Gainers: Phoenix Tree (DNK) +91%.Naked Brand (NAKD) +64%.Kazia Therapeutics (KZIA) +32%.Micro Focus International (MFGP) +32%.BELLUS Health (BLU) +31%.InnSuites Hospitality Trust (IHT) +27%.FuelCell Energy (FCEL) +27%.Ashford Hospitality Trust (AHT) +24%.CIIG Merger (CIIC) ...

Cassava Sciences (NASDAQ: SAVA )   +27%  on insider buying. More news on: Cassava Sciences, Inc., Immutep Limited, ClearOne, Inc., , Stocks on the move, Read more ...

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, oral care, nasal care and dermatological conditions, and its partner, the MicroSafe G...

Sonoma Pharmaceuticals (NASDAQ: SNOA )  and partner, Te Arai BioFarma have launched two new products - Nasocyn Nasal Care and Oracyn Oral Care in Australia. More news on: Sonoma Pharmaceuticals, Inc., Healthcare stocks news, Stocks on the move, Read more ...